PAPER Salunkhe J, Ugale R

Recent updates on immunotherapy in neurodegenerative diseases.

Brain Res. 2024 Aug 27;1845:149205. PubMed.

Bill Hoffman

Donna Smith

St. Petersburg, United States

Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01- Clinical Trial Optional) (PAR-24-273)

GRANT Friday, August 30, 2024- 1:45pm National Institutes of Health Multiple due dates; see announcement. https://grants.nih.gov/grants/guide/pa-files/PAR-24-273.html 08 Jan 2028

The Impact of Stressors on the Biological Mechanisms of Aging and Other Aging-Associated Outcomes in Experimental Model Systems (R61/R33 Clinical Trial Not allowed) (RFA-AG-25-019)

GRANT Friday, August 30, 2024- 1:45pm National Institute on Aging For the R61 exploratory phase, the combined budget for direct costs for the two-year project period may not exceed $500,000, with no more than $250,000 requested in any single year. For the three

Short Courses Promoting Cross-National Analyses Using Data from the International Health and Retirement Study (HRS) and Harmonized Cognitive Assessment Protocol (HCAP) (R25 Clinical Trial Not Allowed) (RFA-AG-25-025)

GRANT Friday, August 30, 2024- 1:45pm National Institute on Aging Direct costs up to $350,000 per year may be requested. The maximum project period is 5 years. October 10, 2024. https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-025.html 11 Oct 2024

Notice of Special Interest (NOSI): Administrative Supplement Program to Add Fluid-based Biomarkers and APOE Genotyping to NINDS ADRD Human Subjects Research Grants (NOT-NS-24-109)

GRANT Friday, August 30, 2024- 1:30pm National Institute of Neurological Disorders and Stroke, National Institute on Aging One-year administrative supplement to provide support for currently active NINDS Alzheimer’s Disease and Alzheimer’s Disease Related Demen

Franklin Tseng

Seattle, United States

Questions, Questions for Donanemab, Lecanemab

CONFERENCE COVERAGE 2024-08-30 Conference Coverage As amyloid immunotherapy is being rolled out, mostly in specialty care thus far, both treating physicians and researchers have many questions about it. Scientists at the Alzheimer’s Association International Conference, held last month

Sarah Savoia

Biggs Institute
San Antonio, United States

EMBO Workshop: Neural Development and Neurodegeneration

CONFERENCE 2025-03-14 00:00:00-2025-03-18 00:00:00 Taipei, Taiwan 14 &#x2013 18 March 2025 View Conference Website 0

Bisrat Woldemichael

Astoria, United States

Colin Masters on Is the ‘Atrophy’ of Immunotherapy Just the Dismantling of Plaque ‘Suburbia’?

COMMENT It is well known that the cortex swells slightly as Alzheimer’s disease develops (see for example recent work from Phan et al., 2024), probably due to reactive changes (gliosis, not inflammation) as the Aβ amyloid aggregates and deposits in the parenchyma

Archana Kumar

VTU
Bangalore, India

PAPER Zhou Q

Deepening insights into the roles of 25-OH vitamin D in alzheimer's disease.

QJM. 2024 Aug 28; PubMed.